摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[2-hydroxy-1-(7H-purin-6-ylamino)ethyl]-3-phenylpyrrolo[1,2-a][1,3,5]triazin-4-one

中文名称
——
中文别名
——
英文名称
2-[2-hydroxy-1-(7H-purin-6-ylamino)ethyl]-3-phenylpyrrolo[1,2-a][1,3,5]triazin-4-one
英文别名
——
2-[2-hydroxy-1-(7H-purin-6-ylamino)ethyl]-3-phenylpyrrolo[1,2-a][1,3,5]triazin-4-one化学式
CAS
——
化学式
C19H16N8O2
mdl
——
分子量
388.4
InChiKey
LJTAEJYPCUTFLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    124
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • PYRROLOTRIAZINONE DERIVATIVES AS P13K INHIBITORS
    申请人:Bernal Anchuela Francisco Javier
    公开号:US20140163033A1
    公开(公告)日:2014-06-12
    New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    本发明公开了具有化学结构公式(I)的新吡咯三唑酮衍生物;以及它们的制备过程,包括它们的药物组合物和它们作为磷脂酰肌醇3-激酶(PI3Ks)抑制剂在治疗中的使用。
  • PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS
    申请人:Bernal Anchuela Francisco Javier
    公开号:US20150099752A9
    公开(公告)日:2015-04-09
    New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    本发明涉及一种具有化学结构式(I)的新型吡咯三唑酮衍生物,以及其制备方法、包含它们的制药组合物和它们作为磷脂酰肌醇3-激酶(PI3Ks)抑制剂在治疗中的应用。
  • COMBINATION
    申请人:Almirall, S.A.
    公开号:US20170151264A1
    公开(公告)日:2017-06-01
    The present invention provides a pharmaceutical composition which comprises (a) a compound which is an inhibitor of phosphoinositide 3-kinase delta or a pharmaceutically acceptable salt and/or solvate thereof, and (b) a corticosteroid.
  • MEDICAL USE
    申请人:Almirall, S.A.
    公开号:US20170189409A1
    公开(公告)日:2017-07-06
    The present invention provides a compound, which is an inhibitor of phosphoinositide 3-kinase delta or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment of an immunobullous skin disease mediated by autoantibodies by oral administration.
  • US9340547B2
    申请人:——
    公开号:US9340547B2
    公开(公告)日:2016-05-17
查看更多